The domestic pharma industry marked a revival in September by clocking 4.5 per cent growth in sales, riding on cardiac, antidiabetic, and vitamin drugs. In August, the market had clocked negative growth of 2.2 per cent, while July growth was little changed at 0.2 per cent.
In fact, barring June (which witnessed a growth of 2.4 per cent), the domestic pharma market has been in negative terrain since the beginning of this financial year. Cardiac therapy grew 17.1 per cent in September, compared to 11.5 per cent growth in August.
Antidiabetics too improved its growth rate from 1.6 per cent in August to 6.5 per cent in September. Vitamins, too, have shown strong growth as people go for immunity-boosting vitamins and minerals like zinc supplements and vitamin C. It clocked a strong 16.3 per cent growth rate in September.
Subscribe To ET Now For Latest Updates On Stocks, Business, Trading | ►
Subscribe Now To Our Network Channels :-
Times Now :
The NewsHour Debate :
To Stay Updated Download the Times Now App :-
Android Google Play :
Apple App Store :
Social Media Links :-
Twitter –
Facebook –
G+ –
Website – www.etnownews.com
